Clinical Trials
2 trialsNCT03575065 2024-10-26
Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China
BeiGene
Phase 2 Completed
NCT04942054 2023-05-22
A Study in Patients With Advanced Breast Cancer
Sun Pharma Advanced Research Company Limited
Phase 1 Terminated